Gilead Sciences stock trades up with weak intraday momentum amid HIV partnership expansion

Traders Union
All News
Companies
Gilead Sciences rises 0.15% today

Highlights

Gilead Sciences continues to face sustained selling pressure, trading below short- and medium-term moving averages with long-term support just below current levels.
Momentum remains weak across multiple indicators, with oversold signals and near-term dominance by sellers.
Price is expected to move sideways or lower within a $127.00 to $133.50 range, with upside probability limited and further declines likely if support breaks.

Persistent selling and fragile support as price tests key averages

Gilead Sciences ($GILD) is trading at $129.18, sitting below the MA-20 ($131.96) and MA-50 ($134.36), while remaining just above the MA-200 ($128.86), which highlights persistent short- and medium-term pressure from sellers, with long-term support close by. The Ichimoku Kijun on D1 is at $132.29, which is above the current price and thus acts as immediate resistance. Near-term support is clustered at the MA-200 ($128.86), with key support at the HMA ($127.56). Immediate resistance stands at the Kijun ($132.29), followed by key resistance at the MA-50 ($134.36).

Sustained weak momentum as sellers drive steady weekly decline

Momentum on D1 remains weak, with MACD signaling a sell bias and ADX showing a low trend strength. RSI, CCI, and Stoch RSI are tilted to the downside, with RSI reading 42.14 and BBP at -0.41 in oversold territory, indicating sellers dominate the current intraday momentum. Awesome Oscillator is neutral, not adding clear confirmation to the overall trend. Over the past week, GILD has fallen $5.25 (3.91%) from a previous weekly close of $134.43, and the current price is in the lower part of the weekly range, with weekly volatility at 7.94%. This points to a steady decline from the high and confirms the recent period of downward momentum.

Downside risk prevails as resistance caps and indicators remain bearish

Looking ahead, the expected trading range for the upcoming week is $127.00 to $133.50, aligning with recent weekly volatility and containing the price well above the 52-week low ($104.46) and below the 52-week high ($157.29). The probability of a price increase next week is very low (less than 20%), making a further decline more likely, as only the MA-50 on W1 provides a Buy signal among key W1 indicators (RSI-W1, ADX-W1, MACD-W1, MA-50-W1). The baseline scenario sees GILD moving sideways within this corridor, weighed down by nearby resistance and lackluster momentum. A bullish scenario would require reclaiming resistance at $132.29 and holding above $134.36 to gain upward traction. On the bearish side, a drop below MA-200 ($128.86) and HMA ($127.56) could trigger further downside, potentially testing lower weekly supports.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Earlier, analysts noted that Gilead Sciences was experiencing sustained seller momentum and faced continued downside pressure amid weakening technical signals. In light of current developments, investors should closely watch for a decisive move above immediate resistance or a breakdown below key support, as confirmation of either could define the prevailing market scenario for GILD in the sessions ahead.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.